NUWELLIS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.256 USD | -1.16% |
|
+3.63% | -55.72% |
| 05-07 | Top Midday Gainers | MT |
| 05-07 | Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Good day and welcome to the Nuwellis, Inc. Fou...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Calendar
2024-06-06
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.259
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -55.72% | 4.68M | |
| +11.87% | 227B | |
| +15.39% | 197B | |
| +18.21% | 141B | |
| +30.02% | 110B | |
| +0.65% | 64.15B | |
| +17.15% | 53.72B | |
| +5.82% | 51.75B | |
| +11.11% | 45.2B | |
| +5.79% | 37.37B |
- Stock Market
- Equities
- NUWE Stock
- News Nuwellis, Inc.
- Transcript : Nuwellis, Inc., Q4 2021 Earnings Call, Mar 01, 2022
